The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
Open accessAbstract
Cardiac hypertrophy is a major cause of morbidity and mortality worldwide. The hypertrophic process is mediated, in part, by small G proteins of the Rho family. We hypothesized that statins, inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase, inhibit cardiac hypertrophy by blocking Rho isoprenylation. We treated neonatal rat cardiac myocytes with angiotensin II (AngII) with and without simvastatin (Sim) and found that Sim decreased AngII-induced protein content, [3H] leucine uptake, and atrial natriuretic factor (ANF) promoter activity. These effects were associated with decreases in cell size, membrane Rho activity, superoxide anion (O2*-) production, and intracellular oxidation, and were reversed with L-mevalonate or geranylgeranylpyrophosphate, but not with farnesylpyrophosphate or cholesterol. Treatments with the Rho inhibitor C3 exotoxin and with cell-permeable superoxide dismutase also decreased AngII-induced O2*- production and myocyte hypertrophy. Overexpression of the dominant-negative Rho mutant N17Rac1 completely inhibited AngII-induced intracellular oxidation and ANF promoter activity, while N19RhoA partially inhibited it, and N17Cdc42 had no effect. Indeed, Sim inhibited cardiac hypertrophy and decreased myocardial Rac1 activity and O2*- production in rats treated with AngII infusion or subjected to transaortic constriction. These findings suggest that statins prevent the development of cardiac hypertrophy through an antioxidant mechanism involving inhibition of Rac1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Nobes, C. D., & Hall, A. (1995) · Cell · doi:10.1016/0092-8674(95)90370-4 · Cited by 4,412
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,652
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase)
Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., Feng, J., Nakano, T., Okawa, K., et al. (1996) · Science · doi:10.1126/science.273.5272.245 · Cited by 2,884
Rho GTPases and signaling networks
Van Aelst, L., & D’Souza-Schorey, C. (1997) · Genes & Development · doi:10.1101/gad.11.18.2295 · Cited by 2,358
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,891
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
Self-citationLeft Ventricular Remodeling After Myocardial Infarction: Pathophysiology and Therapy
Sutton, M. G. S. J., & Sharpe, N. (2000) · Circulation · doi:10.1161/01.cir.101.25.2981 · Cited by 1,824
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765 · cited 1×
“Rates of O2· ̄ production were calculated as described (26).”
MethodPost-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase
Laufs, U., & Liao, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24266 · Cited by 1,035 · cited 2×
“, Santa Cruz, California, USA) as described (24).”
MethodSelf-citationChien, K. R., Knowlton, K. U., Zhu, G., & Chien, S. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1835945 · Cited by 794
Protein Lipidation in Cell Signaling
Casey, P. J. (1995) · Science · doi:10.1126/science.7716512 · Cited by 774
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Trends in Cell Biology · doi:10.1016/0962-8924(92)90174-l · Cited by 755
Regulation of Phagocyte Oxygen Radical Production by the GTP-Binding Protein Rac 2
Knaus, U. G., Heyworth, P. G., Evans, T., Curnutte, J. T., & Bokoch, G. M. (1991) · Science · doi:10.1126/science.1660188 · Cited by 525
Nakamura, K., Fushimi, K., Kouchi, H., Mihara, K., Miyazaki, M., Ohe, T., & Namba, M. (1998) · Circulation · doi:10.1161/01.cir.98.8.794 · Cited by 510
Calderone, A., Thaik, C. M., Takahashi, N., Chang, D. L., & Colucci, W. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119883 · Cited by 490
Regulation of reactive-oxygen-species generation in fibroblasts by Rac 1
SUNDARESAN, M., YU, Z.-X., FERRANS, V. J., SULCINER, D. J., GUTKIND, S., IRANI, K. J., GOLDSCHMIDT-CLERMONT, P. J., & FINKEL, T. (1996) · Biochemical Journal · doi:10.1042/bj3180379 · Cited by 486
The role of iron in the activation-inactivation of aconitase.
Kennedy, M. C., Emptage, M. H., Dreyer, J. L., & Beinert, H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44390-0 · Cited by 377
Increased superoxide anion release from human endothelial cells in response to cytokines.
Matsubara, T., & Ziff, M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.10.3295 · Cited by 361
Patel, R., Nagueh, S. F., Tsybouleva, N., Abdellatif, M., Lutucuta, S., Kopelen, H. A., Quinones, M. A., Zoghbi, W. A., Entman, M. L., Roberts, R., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.317 · Cited by 357
Gardner, P. R., & Fridovich, I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50343-x · Cited by 346
Wassmann, S., Laufs, U., Bäumer, A. T., Müller, K., Konkol, C., Sauer, H., Böhm, M., & Nickenig, G. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12257-2 · Cited by 345
Mende, U., Kagen, A., Cohen, A., Aramburu, J., Schoen, F. J., & Neer, E. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13893 · Cited by 258
Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout Mice
Harada, K., Komuro, I., Shiojima, I., Hayashi, D., Kudoh, S., Mizuno, T., Kijima, K., Matsubara, H., Sugaya, T., Murakami, K., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1952 · Cited by 254
Sah, V. P., Minamisawa, S., Tam, S. P., Wu, T. H., Dorn, G. W., Ross, J., Chien, K. R., & Brown, J. H. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6842 · Cited by 251
The Role of Hypertension in the Pathogenesis of Heart Failure: A Clinical Mechanistic Overview
Vasan, R. S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440150033003 · Cited by 247
Angiotensin II Induces Cardiac Phenotypic Modulation and Remodeling In Vivo in Rats
Kim, S., Ohta, K., Hamaguchi, A., Yukimura, T., Miura, K., & Iwao, H. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1252 · Cited by 246
Knowlton, K. U., Baracchini, E., Ross, R. S., Harris, A. N., Henderson, S. A., Evans, S. M., Glembotski, C. C., & Chien, K. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89515-5 · Cited by 244
Aoki, H., Izumo, S., & Sadoshima, J. (1998) · Circulation Research · doi:10.1161/01.res.82.6.666 · Cited by 226
Rho Is Required for Gαq and α1-Adrenergic Receptor Signaling in Cardiomyocytes
Sah, V. P., Hoshijima, M., Chien, K. R., & Brown, J. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31185 · Cited by 219
RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload
Rogers, J. H., Tamirisa, P., Kovacs, A., Weinheimer, C., Courtois, M., Blumer, K. J., Kelly, D. P., & Muslin, A. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6713 · Cited by 197
Hoshijima, M., Sah, V. P., Wang, Y., Chien, K. R., & Brown, J. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7725 · Cited by 189
Gq Signaling in Cardiac Adaptation and Maladaptation
Dorn, G. (1999) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(99)00004-3 · Cited by 174
Bacterial toxins that target Rho proteins.
Aktories, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119245 · Cited by 171
Shubeita, H. E., Martinson, E. A., Van Bilsen, M., Chien, K. R., & Brown, J. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1305 · Cited by 168
Pracyk, J. B., Tanaka, K., Hegland, D. D., Kim, K. S., Sethi, R., Rovira, I. I., Blazina, D. R., Lee, L., Bruder, J. T., Kovesdi, I., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2552 · Cited by 148
Ramires, F. J. A., Sun, Y., & Weber, K. T. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0612 · Cited by 125
Luo, J., Zhang, W., Zhang, G., Guan, J., & Chen, X. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03165.x · Cited by 116
Springhorn, J. P., & Claycomb, W. C. (1989) · Biochemical Journal · doi:10.1042/bj2580073 · Cited by 112
Nitric oxide controls cardiac substrate utilization in the conscious dog
Recchia, F. A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00245-x · Cited by 73
Libby, P. (1984) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(84)80004-8 · Cited by 52
Signaling Pathways for Cardiac Growth and Hypertrophy
Lembo, G., HUNTER, J. J., & Chien, K. R. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17414.x · Cited by 30
Cited by
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Self-citationOxygen, oxidative stress, hypoxia, and heart failure
Giordano, F. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524408 · Cited by 1,496
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Pleiotropic Effects of Statins on the Cardiovascular System
Oesterle, A., Laufs, U., & Liao, J. K. (2017) · Circulation Research · doi:10.1161/circresaha.116.308537 · Cited by 1,247
Self-citationBeneficial Cardiovascular Pleiotropic Effects of Statins
Davignon, J. (2004) · Circulation · doi:10.1161/01.cir.0000131517.20177.5a · Cited by 955
Metadata
- Authors
- Takemoto, M., Node, K., Nakagami, H., Liao, Y., Grimm, M., Takemoto, Y., Kitakaze, M., & Liao, J. K.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-11-15
- Volume
- 108
- Issue
- 10
- Pages
- 1429-1437
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2051441972
- Cited by
- 491
- References
- 50
- FWCI
- 21.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.